C150 Special Treatment

Flind Pharmaceuticals had been established for less than a month. Yet, with Chu Chenglong's initial investment of 800 million and Rainsong Pavilion's overt and covert support, the company's framework was solidly in place. Just yesterday, Chu Chenglong had poured an additional five billion into the firm, eliminating any financial concerns for Flind. If more funds were needed